Skip to main content

Table 3 Tumor gene expression to platinum-containing treatment in responders and non-responders

From: Peritoneal carcinomatosis from ovarian cancer: chemosensitivity test and tissue markers as predictors of response to chemotherapy

  Median expression values (range)
Gene Total patients Responders Non-responders p
MGMT 0.90 (0-20.0) 0.57 (0-2.2) 2.0 (0-20.0) 0.03
XPD 0.80 (0.027-12.4) 0.52 (0.027-2.0) 1.9 (0.11-12.4) 0.04
BRCA1 2.60 (0-87.4) 1.73 (0.20-6.47) 3.0 (0-87.4) 0.59
ERCC1 1.50 (0.47-15.0) 2.30 (0.7-7.02) 1.4 (0.47-15.0) 0.93
GSTP1 1.75 (0.15-45.0) 1.47 (0.15-7.5) 1.7 (0.71-45.0) 0.65